Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name ‘Invicta Diagnostic LLP’ on January 22, 2021. Further, Invicta Diagnostic LLP was converted into a private limited company ‘Invicta Diagnostic Private Limited’ on December 1, 2023. Subsequently, the company was converted from a private limited company to a public limited company, pursuant to a resolution passed in the extraordinary general meeting of the shareholders held on April 20, 2024 and the name of the company was changed to ‘Invicta Diagnostic Limited’ on July 2, 2024.

The company is a diagnostic chain in Mumbai Metropolitan Region (MMR) offering radiology and pathology solutions. It offers pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory and teleradiology to customers under the brand name ‘PC Diagnostics’ through its operational network, which consists of diagnostic centres and centralised laboratory across Mumbai Metropolitan Region in the state of Maharashtra. 

It has implemented a ‘hub and spoke’ model across MMR which are either directly or through its subsidiaries, whereby specimens are collected across multiple locations within a catchment area or region for delivery to the company’s reference centres for diagnostic testing. This model provides greater economies of scale and enhances consistency in its testing procedures and results. All of its centres offer integrated diagnostics services (pathology and radiology tests under one roof) with smaller spokes offering pathology tests and basic radiology tests and hub centres offering pathology tests, basic radiology tests and advanced radiology tests such as MRI, CT and PET CT.

Business area of the company

The company is primarily engaged in the service of diagnostic chain offering comprehensive radiology and pathology solutions. 

Services of the company

Radiology 

• Basic Radiology Tests - Its basic radiology tests include ECG, X-rays, and ultrasounds.
• Advanced Radiology Tests - Its advanced radiology tests include CT scans and MRI scans and highly specialized nuclear medicine tests such PET-CT scans, which require advanced machinery to conduct such tests.

Pathology

• Routine Testing - Its routine tests include basic biochemistry, basic haematology, clinical pathology which are performed at its own centres and surgical/anatomic pathology, microbiology and cytology tests are outsourced to reference laboratories.
• Specialized Testing - Its specialized test includes advanced biochemistry, chemiluminescence immunoassay (CLIA) that combine chemiluminescence technique with immunochemical reactions.

Awards, accreditations and recognition 

• 2024: Recipient at the Great Indian Healthcare Leaders’ Summit and Awards 2024 under the category of ‘Great Indian Radiology Centre’.

History and milestones

• 2021: Incorporation of Erstwhile LLP.
• 2021: Setting up of 1st fully integrated Diagnostic Centre in Thane having the entire gamut of services under its umbrella including PET CT scans, CT scans, MRI Scans, Sonography, X-Ray and Pathology.
• 2023: Conversion of Erstwhile LLP into a private limited company ‘Invicta Diagnostic Private Limited’ pursuant to the provisions of Chapter XXI of the Companies Act, 2013.
• 2023: Acquisition of majority shareholding in ‘PCD Diagnostics LLP’ for a full-fledged diagnostic centre in Marol, Andheri East, forming it as the company’s subsidiary.
• 2023: Acquisition of majority shareholding in ‘Primacare Healthcare LLP’ for a full-fledged diagnostic centre in Byculla, forming it as the company’s subsidiary.
• 2023: Acquisition of majority shareholding in ‘Pratham MRI and CT Scan Centre’ for a full-fledged diagnostic centre in Bhayandar, forming it as the company’s subsidiary.
• 2024: Acquisition of a diagnostic centre in Sewri from PCD Medical LLP.
• 2024: Acquisition of a diagnostic centre in Parel from Primacare Diagnostic LLP.
• 2024: Acquisition of a centralised laboratory in Parel from Porteus Path Lab LLP.
• 2024: Formation of the subsidiary ‘Invicta Medical LLP’ for setting up of diagnostic centre in Kalwa, Thane. 
• 2024: Conversion from Private Limited to Public Limited Company.
• 2025: Acquisition of ‘Porteus Medical LLP’ (Formerly known as ‘Porteus Porteus Path Lab LLP’) for forming it as the company’s subsidiary.
• 2025: Acquisition of ‘Primacare Diagnostic LLP’ for setting up of diagnostic centre in Dadar, Mumbai, forming it as the company’s subsidiary.
• 2025: Acquisition of ‘MSCRIBEIT Infotech LLP’ (Formerly Knowns as ‘PCD Medical LLP’) forming it as the company’s Associate.